Brief: Solvonis Therapeutics Says SVN-114 Selected As Lead Candidate For PTSD Discovery Programme
March 10 (Reuters) - Solvonis Therapeutics PLC SVNS.L: SOLVONIS THERAPEUTICS PLC: SVN-114 SELECTED AS LEAD CANDIDATE FOR PTSD DISCOVERY PROGRAMME Source text: ID:nRSJ9244Va Further company coverage: SVNS.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solvonis Therapeutics
See all newsBrief: Solvonis Therapeutics Plans IND Submission For Phase 2B Trial Of SVN-2 In U.S.
Solvonis Therapeutic - Announces Positive Bridging Data Supporting
Solvonis Therapeutic - Notice of Annual General Meeting
RCS - Solvonis Therapeutic - CSO Speaks at National Research Meeting
Solvonis Therapeutic - Final Results